Fighting nausea in the '90s: more and better anti-emetics can help.
Saphir
A
A
D000932:Antiemetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003907:Dexamethasone / Q000627:therapeutic use; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D017829:Granisetron / Q000627:therapeutic use; D006801:Humans; D007540:Isonipecotic Acids / Q000627:therapeutic use; D009325:Nausea / Q000139:chemically induced / Q000503:physiopathology / Q000517:prevention & control*; D017294:Ondansetron / Q000627:therapeutic use; D012702:Serotonin Antagonists / Q000627:therapeutic use*; D013373:Substance P / Q000627:therapeutic use; D014839:Vomiting / Q000139:chemically induced / Q000503:physiopathology / Q000517:prevention & control*
D000932:Antiemetics; D000970:Antineoplastic Agents; D003907:Dexamethasone; D017829:Granisetron; D007540:Isonipecotic Acids; D017294:Ondansetron; D012702:Serotonin Antagonists; D013373:Substance P; C005260:metopimazine